Zhi-Ping Li Selected Research

Zhi-Ping Li Research Topics

Disease

10	Neoplasms (Cancer) 11/2022 - 01/2016
6	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 06/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2019
3	Body Weight (Weight, Body) 08/2020 - 05/2020
2	Lupus Nephritis 02/2021 - 08/2020
2	Chemical and Drug Induced Liver Injury 05/2020 - 08/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2018 - 06/2017
2	Asthma (Bronchial Asthma) 01/2014 - 12/2012
1	Papillary Thyroid Cancer 11/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2022
1	Hyperthermia 10/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2021
1	Neuroblastoma 05/2021
1	Ototoxicity 05/2021
1	Drug-Related Side Effects and Adverse Reactions 05/2021
1	Hypersensitivity (Allergy) 05/2021
1	Infections 05/2021
1	AIDS-Related Complex (ARC) 02/2021
1	Proteinuria 02/2021
1	Disease Progression 01/2021
1	Obesity 10/2020
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Weight Gain 10/2020
1	Ovarian Neoplasms (Ovarian Cancer) 09/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 04/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Liver Neoplasms (Liver Cancer) 03/2018
1	Hemolysis 01/2018
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2018
1	Cardiotoxicity 01/2018
1	Carcinoma (Carcinomatosis) 01/2016
1	Reperfusion Injury 01/2016

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 05/2021 - 12/2012
4	Tacrolimus (Prograf)FDA LinkGeneric 02/2021 - 05/2020
4	Capsules (Microcapsules)IBA 08/2020 - 08/2019
4	wuzhiIBA 08/2020 - 08/2019
4	ProdrugsIBA 03/2019 - 01/2016
3	raltitrexed (D 1694)IBA 01/2022 - 01/2019
3	Cytochrome P-450 CYP3AIBA 08/2020 - 05/2020
3	Fluorouracil (Carac)FDA LinkGeneric 03/2019 - 11/2017
3	PectinsIBA 03/2018 - 01/2016
2	Contrast MediaIBA 11/2022 - 01/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2021
2	SaltsIBA 02/2021 - 02/2020
2	Proteins (Proteins, Gene)FDA Link 09/2020 - 06/2004
2	Sirolimus (Rapamycin)FDA Link 08/2020 - 01/2020
2	schizandrer AIBA 05/2020 - 08/2019
2	schizandrol BIBA 05/2020 - 08/2019
2	schizandrinIBA 05/2020 - 08/2019
2	Phosphotransferases (Kinase)IBA 07/2018 - 06/2017
2	Sorafenib (BAY 43-9006)FDA Link 07/2018 - 06/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2018 - 01/2018
2	Therapeutic UsesIBA 03/2018 - 12/2008
2	MicellesIBA 03/2018 - 01/2016
1	LipidsIBA 11/2022
1	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 10/2022
1	PrionsIBA 10/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2022
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 07/2022
1	Vancomycin FDA LinkGeneric 05/2021
1	LithiumIBA 02/2021
1	CarbonatesIBA 02/2021
1	SolventsIBA 02/2021
1	bis(trifluoromethanesulfonyl)imideIBA 02/2021
1	BoratesIBA 02/2021
1	ElectrolytesIBA 02/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 10/2020
1	Metformin (Glucophage)FDA LinkGeneric 10/2020
1	Cisplatin (Platino)FDA LinkGeneric 09/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2020
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2019
1	Thymidylate SynthaseIBA 01/2019
1	LuteolinIBA 07/2018
1	ChitosanIBA 03/2018
1	Bovine Serum AlbuminIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	apatinibIBA 01/2018
1	SilymarinIBA 01/2018
1	AnthracyclinesIBA 01/2018
1	Asialoglycoprotein ReceptorIBA 11/2017
1	wogoninIBA 06/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2016
1	Gemcitabine FDA Link 01/2016

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2016
8	Drug Therapy (Chemotherapy) 01/2022 - 01/2016
2	Chemoradiotherapy 01/2020 - 12/2008
2	Radiotherapy 12/2008 - 01/2008
1	Radiofrequency Ablation 02/2020
1	Lymph Node Excision (Lymph Node Dissection) 02/2020